NCT05230771View on ClinicalTrials.gov

Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2027

Conditions
Metastatic Gastric CancerSurgeryChemotherapy
Interventions
COMBINATION_PRODUCT

Palliative surgery after translational therapy

"A total, distal, or proximal gastrectomy with D1 lymph node dissection was done depending on tumour after translational therapy .~location."

DRUG

Chemotheraoy along

Patients receive only the prescribed chemotherapy.

All Listed Sponsors
lead

Fujian Medical University

OTHER

NCT05230771 - Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer | Biotech Hunter | Biotech Hunter